ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Continuous Manufacturing lines for Pharma Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-0N17745
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Continuous Manufacturing lines for Pharma Market Research Report 2024
BUY CHAPTERS

Global Continuous Manufacturing lines for Pharma Market Research Report 2024

Code: QYRE-Auto-0N17745
Report
June 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Manufacturing Co
EMA
FDA
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK Biotek
KORSCH
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens AG
Copa-Data
Asymchem Laboratories (Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech

Continuous Manufacturing lines for Pharma Market

Continuous manufacturing lines for pharmaceuticals refer to an advanced method of drug production where the entire process, from raw material input to final product output, occurs in a seamless, nonstop sequence. This approach contrasts with traditional batch manufacturing, which involves producing drugs in discrete, separate steps with intervals for quality checks and transfers between stages.
Regulatory bodies like the FDA and EMA support the adoption of continuous manufacturing due to its potential to improve product quality and manufacturing efficiency. However, implementing continuous manufacturing requires rigorous validation and compliance with regulatory standards to ensure the safety and efficacy of the pharmaceutical products.
The global Continuous Manufacturing lines for Pharma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Continuous Manufacturing lines for Pharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Continuous Manufacturing lines for Pharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Continuous Manufacturing lines for Pharma in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Continuous Manufacturing lines for Pharma include GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Continuous Manufacturing lines for Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Manufacturing lines for Pharma.
The Continuous Manufacturing lines for Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Manufacturing lines for Pharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Manufacturing lines for Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Continuous Manufacturing lines for Pharma Market Report

Report Metric Details
Report Name Continuous Manufacturing lines for Pharma Market
Segment by Type
  • Solid Dosage Forms
  • Liquid Dosage Forms
Segment by Application
  • Pharmaceutical Companies
  • Contract Manufacturing Organization
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, Shionogi, SK biotek, Korsch, Chemtrix, Fette Compacting, Gericke, Thermo Fisher Scientific, Coperion, Siemens, Copa-DATA, Asymchem Laboratories(Tianjin), Porton Pharma Solutions, Zhejiang Canaan Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Continuous Manufacturing lines for Pharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Continuous Manufacturing lines for Pharma Market report?

Ans: The main players in the Continuous Manufacturing lines for Pharma Market are GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, Shionogi, SK biotek, Korsch, Chemtrix, Fette Compacting, Gericke, Thermo Fisher Scientific, Coperion, Siemens, Copa-DATA, Asymchem Laboratories(Tianjin), Porton Pharma Solutions, Zhejiang Canaan Tech

What are the Application segmentation covered in the Continuous Manufacturing lines for Pharma Market report?

Ans: The Applications covered in the Continuous Manufacturing lines for Pharma Market report are Pharmaceutical Companies, Contract Manufacturing Organization

What are the Type segmentation covered in the Continuous Manufacturing lines for Pharma Market report?

Ans: The Types covered in the Continuous Manufacturing lines for Pharma Market report are Solid Dosage Forms, Liquid Dosage Forms

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Manufacturing lines for Pharma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solid Dosage Forms
1.2.3 Liquid Dosage Forms
1.3 Market by Application
1.3.1 Global Continuous Manufacturing lines for Pharma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Manufacturing lines for Pharma Market Perspective (2019-2030)
2.2 Global Continuous Manufacturing lines for Pharma Growth Trends by Region
2.2.1 Global Continuous Manufacturing lines for Pharma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Manufacturing lines for Pharma Historic Market Size by Region (2019-2024)
2.2.3 Continuous Manufacturing lines for Pharma Forecasted Market Size by Region (2025-2030)
2.3 Continuous Manufacturing lines for Pharma Market Dynamics
2.3.1 Continuous Manufacturing lines for Pharma Industry Trends
2.3.2 Continuous Manufacturing lines for Pharma Market Drivers
2.3.3 Continuous Manufacturing lines for Pharma Market Challenges
2.3.4 Continuous Manufacturing lines for Pharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Manufacturing lines for Pharma Players by Revenue
3.1.1 Global Top Continuous Manufacturing lines for Pharma Players by Revenue (2019-2024)
3.1.2 Global Continuous Manufacturing lines for Pharma Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Manufacturing lines for Pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Continuous Manufacturing lines for Pharma Revenue
3.4 Global Continuous Manufacturing lines for Pharma Market Concentration Ratio
3.4.1 Global Continuous Manufacturing lines for Pharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Manufacturing lines for Pharma Revenue in 2023
3.5 Global Key Players of Continuous Manufacturing lines for Pharma Head office and Area Served
3.6 Global Key Players of Continuous Manufacturing lines for Pharma, Product and Application
3.7 Global Key Players of Continuous Manufacturing lines for Pharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Manufacturing lines for Pharma Breakdown Data by Type
4.1 Global Continuous Manufacturing lines for Pharma Historic Market Size by Type (2019-2024)
4.2 Global Continuous Manufacturing lines for Pharma Forecasted Market Size by Type (2025-2030)
5 Continuous Manufacturing lines for Pharma Breakdown Data by Application
5.1 Global Continuous Manufacturing lines for Pharma Historic Market Size by Application (2019-2024)
5.2 Global Continuous Manufacturing lines for Pharma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Manufacturing lines for Pharma Market Size (2019-2030)
6.2 North America Continuous Manufacturing lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024)
6.4 North America Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Manufacturing lines for Pharma Market Size (2019-2030)
7.2 Europe Continuous Manufacturing lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024)
7.4 Europe Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Manufacturing lines for Pharma Market Size (2019-2030)
8.2 Asia-Pacific Continuous Manufacturing lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Continuous Manufacturing lines for Pharma Market Size by Region (2019-2024)
8.4 Asia-Pacific Continuous Manufacturing lines for Pharma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Manufacturing lines for Pharma Market Size (2019-2030)
9.2 Latin America Continuous Manufacturing lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024)
9.4 Latin America Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Manufacturing lines for Pharma Market Size (2019-2030)
10.2 Middle East & Africa Continuous Manufacturing lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024)
10.4 Middle East & Africa Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GEA Group
11.1.1 GEA Group Company Details
11.1.2 GEA Group Business Overview
11.1.3 GEA Group Continuous Manufacturing lines for Pharma Introduction
11.1.4 GEA Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.1.5 GEA Group Recent Development
11.2 Glatt Group
11.2.1 Glatt Group Company Details
11.2.2 Glatt Group Business Overview
11.2.3 Glatt Group Continuous Manufacturing lines for Pharma Introduction
11.2.4 Glatt Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.2.5 Glatt Group Recent Development
11.3 IMA Group
11.3.1 IMA Group Company Details
11.3.2 IMA Group Business Overview
11.3.3 IMA Group Continuous Manufacturing lines for Pharma Introduction
11.3.4 IMA Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.3.5 IMA Group Recent Development
11.4 LB Bohle
11.4.1 LB Bohle Company Details
11.4.2 LB Bohle Business Overview
11.4.3 LB Bohle Continuous Manufacturing lines for Pharma Introduction
11.4.4 LB Bohle Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.4.5 LB Bohle Recent Development
11.5 Hovione
11.5.1 Hovione Company Details
11.5.2 Hovione Business Overview
11.5.3 Hovione Continuous Manufacturing lines for Pharma Introduction
11.5.4 Hovione Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.5.5 Hovione Recent Development
11.6 Continuus Pharmaceuticals
11.6.1 Continuus Pharmaceuticals Company Details
11.6.2 Continuus Pharmaceuticals Business Overview
11.6.3 Continuus Pharmaceuticals Continuous Manufacturing lines for Pharma Introduction
11.6.4 Continuus Pharmaceuticals Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.6.5 Continuus Pharmaceuticals Recent Development
11.7 Syntegon
11.7.1 Syntegon Company Details
11.7.2 Syntegon Business Overview
11.7.3 Syntegon Continuous Manufacturing lines for Pharma Introduction
11.7.4 Syntegon Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.7.5 Syntegon Recent Development
11.8 Repligen
11.8.1 Repligen Company Details
11.8.2 Repligen Business Overview
11.8.3 Repligen Continuous Manufacturing lines for Pharma Introduction
11.8.4 Repligen Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.8.5 Repligen Recent Development
11.9 Dec Group
11.9.1 Dec Group Company Details
11.9.2 Dec Group Business Overview
11.9.3 Dec Group Continuous Manufacturing lines for Pharma Introduction
11.9.4 Dec Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.9.5 Dec Group Recent Development
11.10 Recipharm
11.10.1 Recipharm Company Details
11.10.2 Recipharm Business Overview
11.10.3 Recipharm Continuous Manufacturing lines for Pharma Introduction
11.10.4 Recipharm Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.10.5 Recipharm Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Continuous Manufacturing lines for Pharma Introduction
11.11.4 Shionogi Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.11.5 Shionogi Recent Development
11.12 SK biotek
11.12.1 SK biotek Company Details
11.12.2 SK biotek Business Overview
11.12.3 SK biotek Continuous Manufacturing lines for Pharma Introduction
11.12.4 SK biotek Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.12.5 SK biotek Recent Development
11.13 Korsch
11.13.1 Korsch Company Details
11.13.2 Korsch Business Overview
11.13.3 Korsch Continuous Manufacturing lines for Pharma Introduction
11.13.4 Korsch Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.13.5 Korsch Recent Development
11.14 Chemtrix
11.14.1 Chemtrix Company Details
11.14.2 Chemtrix Business Overview
11.14.3 Chemtrix Continuous Manufacturing lines for Pharma Introduction
11.14.4 Chemtrix Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.14.5 Chemtrix Recent Development
11.15 Fette Compacting
11.15.1 Fette Compacting Company Details
11.15.2 Fette Compacting Business Overview
11.15.3 Fette Compacting Continuous Manufacturing lines for Pharma Introduction
11.15.4 Fette Compacting Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.15.5 Fette Compacting Recent Development
11.16 Gericke
11.16.1 Gericke Company Details
11.16.2 Gericke Business Overview
11.16.3 Gericke Continuous Manufacturing lines for Pharma Introduction
11.16.4 Gericke Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.16.5 Gericke Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Continuous Manufacturing lines for Pharma Introduction
11.17.4 Thermo Fisher Scientific Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 Coperion
11.18.1 Coperion Company Details
11.18.2 Coperion Business Overview
11.18.3 Coperion Continuous Manufacturing lines for Pharma Introduction
11.18.4 Coperion Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.18.5 Coperion Recent Development
11.19 Siemens
11.19.1 Siemens Company Details
11.19.2 Siemens Business Overview
11.19.3 Siemens Continuous Manufacturing lines for Pharma Introduction
11.19.4 Siemens Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.19.5 Siemens Recent Development
11.20 Copa-DATA
11.20.1 Copa-DATA Company Details
11.20.2 Copa-DATA Business Overview
11.20.3 Copa-DATA Continuous Manufacturing lines for Pharma Introduction
11.20.4 Copa-DATA Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.20.5 Copa-DATA Recent Development
11.21 Asymchem Laboratories(Tianjin)
11.21.1 Asymchem Laboratories(Tianjin) Company Details
11.21.2 Asymchem Laboratories(Tianjin) Business Overview
11.21.3 Asymchem Laboratories(Tianjin) Continuous Manufacturing lines for Pharma Introduction
11.21.4 Asymchem Laboratories(Tianjin) Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.21.5 Asymchem Laboratories(Tianjin) Recent Development
11.22 Porton Pharma Solutions
11.22.1 Porton Pharma Solutions Company Details
11.22.2 Porton Pharma Solutions Business Overview
11.22.3 Porton Pharma Solutions Continuous Manufacturing lines for Pharma Introduction
11.22.4 Porton Pharma Solutions Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.22.5 Porton Pharma Solutions Recent Development
11.23 Zhejiang Canaan Tech
11.23.1 Zhejiang Canaan Tech Company Details
11.23.2 Zhejiang Canaan Tech Business Overview
11.23.3 Zhejiang Canaan Tech Continuous Manufacturing lines for Pharma Introduction
11.23.4 Zhejiang Canaan Tech Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024)
11.23.5 Zhejiang Canaan Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Manufacturing Co
EMA
FDA
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK Biotek
KORSCH
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens AG
Copa-Data
Asymchem Laboratories (Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech
List of Tables
 Table 1. Global Continuous Manufacturing lines for Pharma Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Solid Dosage Forms
 Table 3. Key Players of Liquid Dosage Forms
 Table 4. Global Continuous Manufacturing lines for Pharma Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Continuous Manufacturing lines for Pharma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Continuous Manufacturing lines for Pharma Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Continuous Manufacturing lines for Pharma Market Share by Region (2019-2024)
 Table 8. Global Continuous Manufacturing lines for Pharma Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Continuous Manufacturing lines for Pharma Market Share by Region (2025-2030)
 Table 10. Continuous Manufacturing lines for Pharma Market Trends
 Table 11. Continuous Manufacturing lines for Pharma Market Drivers
 Table 12. Continuous Manufacturing lines for Pharma Market Challenges
 Table 13. Continuous Manufacturing lines for Pharma Market Restraints
 Table 14. Global Continuous Manufacturing lines for Pharma Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Continuous Manufacturing lines for Pharma Market Share by Players (2019-2024)
 Table 16. Global Top Continuous Manufacturing lines for Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Manufacturing lines for Pharma as of 2023)
 Table 17. Ranking of Global Top Continuous Manufacturing lines for Pharma Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Continuous Manufacturing lines for Pharma Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Continuous Manufacturing lines for Pharma, Headquarters and Area Served
 Table 20. Global Key Players of Continuous Manufacturing lines for Pharma, Product and Application
 Table 21. Global Key Players of Continuous Manufacturing lines for Pharma, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Continuous Manufacturing lines for Pharma Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Continuous Manufacturing lines for Pharma Revenue Market Share by Type (2019-2024)
 Table 25. Global Continuous Manufacturing lines for Pharma Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Continuous Manufacturing lines for Pharma Revenue Market Share by Type (2025-2030)
 Table 27. Global Continuous Manufacturing lines for Pharma Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Continuous Manufacturing lines for Pharma Revenue Market Share by Application (2019-2024)
 Table 29. Global Continuous Manufacturing lines for Pharma Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Continuous Manufacturing lines for Pharma Revenue Market Share by Application (2025-2030)
 Table 31. North America Continuous Manufacturing lines for Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Continuous Manufacturing lines for Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Continuous Manufacturing lines for Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Continuous Manufacturing lines for Pharma Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Continuous Manufacturing lines for Pharma Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Continuous Manufacturing lines for Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Continuous Manufacturing lines for Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Continuous Manufacturing lines for Pharma Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Continuous Manufacturing lines for Pharma Market Size by Country (2025-2030) & (US$ Million)
 Table 46. GEA Group Company Details
 Table 47. GEA Group Business Overview
 Table 48. GEA Group Continuous Manufacturing lines for Pharma Product
 Table 49. GEA Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 50. GEA Group Recent Development
 Table 51. Glatt Group Company Details
 Table 52. Glatt Group Business Overview
 Table 53. Glatt Group Continuous Manufacturing lines for Pharma Product
 Table 54. Glatt Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 55. Glatt Group Recent Development
 Table 56. IMA Group Company Details
 Table 57. IMA Group Business Overview
 Table 58. IMA Group Continuous Manufacturing lines for Pharma Product
 Table 59. IMA Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 60. IMA Group Recent Development
 Table 61. LB Bohle Company Details
 Table 62. LB Bohle Business Overview
 Table 63. LB Bohle Continuous Manufacturing lines for Pharma Product
 Table 64. LB Bohle Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 65. LB Bohle Recent Development
 Table 66. Hovione Company Details
 Table 67. Hovione Business Overview
 Table 68. Hovione Continuous Manufacturing lines for Pharma Product
 Table 69. Hovione Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 70. Hovione Recent Development
 Table 71. Continuus Pharmaceuticals Company Details
 Table 72. Continuus Pharmaceuticals Business Overview
 Table 73. Continuus Pharmaceuticals Continuous Manufacturing lines for Pharma Product
 Table 74. Continuus Pharmaceuticals Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 75. Continuus Pharmaceuticals Recent Development
 Table 76. Syntegon Company Details
 Table 77. Syntegon Business Overview
 Table 78. Syntegon Continuous Manufacturing lines for Pharma Product
 Table 79. Syntegon Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 80. Syntegon Recent Development
 Table 81. Repligen Company Details
 Table 82. Repligen Business Overview
 Table 83. Repligen Continuous Manufacturing lines for Pharma Product
 Table 84. Repligen Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 85. Repligen Recent Development
 Table 86. Dec Group Company Details
 Table 87. Dec Group Business Overview
 Table 88. Dec Group Continuous Manufacturing lines for Pharma Product
 Table 89. Dec Group Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 90. Dec Group Recent Development
 Table 91. Recipharm Company Details
 Table 92. Recipharm Business Overview
 Table 93. Recipharm Continuous Manufacturing lines for Pharma Product
 Table 94. Recipharm Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 95. Recipharm Recent Development
 Table 96. Shionogi Company Details
 Table 97. Shionogi Business Overview
 Table 98. Shionogi Continuous Manufacturing lines for Pharma Product
 Table 99. Shionogi Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 100. Shionogi Recent Development
 Table 101. SK biotek Company Details
 Table 102. SK biotek Business Overview
 Table 103. SK biotek Continuous Manufacturing lines for Pharma Product
 Table 104. SK biotek Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 105. SK biotek Recent Development
 Table 106. Korsch Company Details
 Table 107. Korsch Business Overview
 Table 108. Korsch Continuous Manufacturing lines for Pharma Product
 Table 109. Korsch Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 110. Korsch Recent Development
 Table 111. Chemtrix Company Details
 Table 112. Chemtrix Business Overview
 Table 113. Chemtrix Continuous Manufacturing lines for Pharma Product
 Table 114. Chemtrix Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 115. Chemtrix Recent Development
 Table 116. Fette Compacting Company Details
 Table 117. Fette Compacting Business Overview
 Table 118. Fette Compacting Continuous Manufacturing lines for Pharma Product
 Table 119. Fette Compacting Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 120. Fette Compacting Recent Development
 Table 121. Gericke Company Details
 Table 122. Gericke Business Overview
 Table 123. Gericke Continuous Manufacturing lines for Pharma Product
 Table 124. Gericke Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 125. Gericke Recent Development
 Table 126. Thermo Fisher Scientific Company Details
 Table 127. Thermo Fisher Scientific Business Overview
 Table 128. Thermo Fisher Scientific Continuous Manufacturing lines for Pharma Product
 Table 129. Thermo Fisher Scientific Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 130. Thermo Fisher Scientific Recent Development
 Table 131. Coperion Company Details
 Table 132. Coperion Business Overview
 Table 133. Coperion Continuous Manufacturing lines for Pharma Product
 Table 134. Coperion Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 135. Coperion Recent Development
 Table 136. Siemens Company Details
 Table 137. Siemens Business Overview
 Table 138. Siemens Continuous Manufacturing lines for Pharma Product
 Table 139. Siemens Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 140. Siemens Recent Development
 Table 141. Copa-DATA Company Details
 Table 142. Copa-DATA Business Overview
 Table 143. Copa-DATA Continuous Manufacturing lines for Pharma Product
 Table 144. Copa-DATA Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 145. Copa-DATA Recent Development
 Table 146. Asymchem Laboratories(Tianjin) Company Details
 Table 147. Asymchem Laboratories(Tianjin) Business Overview
 Table 148. Asymchem Laboratories(Tianjin) Continuous Manufacturing lines for Pharma Product
 Table 149. Asymchem Laboratories(Tianjin) Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 150. Asymchem Laboratories(Tianjin) Recent Development
 Table 151. Porton Pharma Solutions Company Details
 Table 152. Porton Pharma Solutions Business Overview
 Table 153. Porton Pharma Solutions Continuous Manufacturing lines for Pharma Product
 Table 154. Porton Pharma Solutions Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 155. Porton Pharma Solutions Recent Development
 Table 156. Zhejiang Canaan Tech Company Details
 Table 157. Zhejiang Canaan Tech Business Overview
 Table 158. Zhejiang Canaan Tech Continuous Manufacturing lines for Pharma Product
 Table 159. Zhejiang Canaan Tech Revenue in Continuous Manufacturing lines for Pharma Business (2019-2024) & (US$ Million)
 Table 160. Zhejiang Canaan Tech Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Continuous Manufacturing lines for Pharma Picture
 Figure 2. Global Continuous Manufacturing lines for Pharma Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Continuous Manufacturing lines for Pharma Market Share by Type: 2023 VS 2030
 Figure 4. Solid Dosage Forms Features
 Figure 5. Liquid Dosage Forms Features
 Figure 6. Global Continuous Manufacturing lines for Pharma Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Continuous Manufacturing lines for Pharma Market Share by Application: 2023 VS 2030
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. Contract Manufacturing Organization Case Studies
 Figure 10. Continuous Manufacturing lines for Pharma Report Years Considered
 Figure 11. Global Continuous Manufacturing lines for Pharma Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Continuous Manufacturing lines for Pharma Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Continuous Manufacturing lines for Pharma Market Share by Region: 2023 VS 2030
 Figure 14. Global Continuous Manufacturing lines for Pharma Market Share by Players in 2023
 Figure 15. Global Top Continuous Manufacturing lines for Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Manufacturing lines for Pharma as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Continuous Manufacturing lines for Pharma Revenue in 2023
 Figure 17. North America Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Continuous Manufacturing lines for Pharma Market Share by Country (2019-2030)
 Figure 19. United States Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. Canada Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Europe Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Continuous Manufacturing lines for Pharma Market Share by Country (2019-2030)
 Figure 23. Germany Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. France Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. U.K. Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Italy Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Russia Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Nordic Countries Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Asia-Pacific Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Continuous Manufacturing lines for Pharma Market Share by Region (2019-2030)
 Figure 31. China Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Japan Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. South Korea Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Southeast Asia Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. India Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Australia Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Latin America Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Continuous Manufacturing lines for Pharma Market Share by Country (2019-2030)
 Figure 39. Mexico Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Brazil Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Middle East & Africa Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Continuous Manufacturing lines for Pharma Market Share by Country (2019-2030)
 Figure 43. Turkey Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Saudi Arabia Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. UAE Continuous Manufacturing lines for Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. GEA Group Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 47. Glatt Group Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 48. IMA Group Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 49. LB Bohle Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 50. Hovione Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 51. Continuus Pharmaceuticals Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 52. Syntegon Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 53. Repligen Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 54. Dec Group Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 55. Recipharm Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 56. Shionogi Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 57. SK biotek Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 58. Korsch Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 59. Chemtrix Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 60. Fette Compacting Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 61. Gericke Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 63. Coperion Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 64. Siemens Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 65. Copa-DATA Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 66. Asymchem Laboratories(Tianjin) Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 67. Porton Pharma Solutions Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 68. Zhejiang Canaan Tech Revenue Growth Rate in Continuous Manufacturing lines for Pharma Business (2019-2024)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Continuous Pharma Production Lines Market Research Report 2024
Global Continuous Processing Lines for Pharma Market Research Report 2024
Continuous Manufacturing in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Continuous Manufacturing Market Research Report 2024
Global Pharma Continuous Granulation Market Research Report 2024
Global Pharma Continuous Blender Market Research Report 2024
Global Pharmaceutical Flexible Manufacturing Systems Market Research Report 2025
Global Commercial Drug Manufacturing Service Market Research Report 2025
Global Pharmaceutical Manufacturing and Processing Equipment Market Research Report 2024
Global Drug Manufacturing Equipment Market Research Report 2024
Global Continuous Mixing Systems Market Research Report 2025
Global Continuous Flow Chromatography System Market Research Report 2025
Global Sterile Injectables Production Line Market Research Report 2025
Global Pharmaceutical Production Equipment Market Research Report 2024
Global Pharma Tablet Coating Systems Market Research Report 2024
Global IoT Spending for Connected Devices Platforms Digital Services in Pharmaceutical Manufacturing Market Insights Forecast to 2030
Global Automated Production Line Market Research Report 2024
Global Coding and Marking Systems for Pharmaceutical Market Research Report 2024
Global Pharmaceutical Supply Chain System Market Research Report 2024
Global Continuous Pickling Line Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions